Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells.
Saved in:
| Title: | Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells. |
|---|---|
| Authors: | Farrash, Wesam F.1 (AUTHOR), Aslam, Akhmed1 (AUTHOR), Almaimani, Riyad2 (AUTHOR), Minshawi, Faisal1 (AUTHOR), Almasmoum, Hussain1 (AUTHOR), Alsaegh, Aiman1 (AUTHOR), Iqbal, Mohammad S.1 (AUTHOR), Tabassum, Aisha1 (AUTHOR), Elzubier, Mohamed E.2 (AUTHOR), El‐Readi, Mahmoud Z.2,3 (AUTHOR), Mahbub, Amani A.1 (AUTHOR), Idris, Shakir1 (AUTHOR), Refaat, Bassem1 (AUTHOR) barefaat@uqu.edu.sa |
| Source: | Biofactors. Jul2023, Vol. 49 Issue 4, p831-848. 18p. |
| Database: | Environment Complete |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
